AARC Corporate Partner Program Adds Bayer Diagnostics
Symbiotic Relationship Expected to Advance Respiratory
For Immediate Release
DALLAS ( November 20, 2003) – The American Association
for Respiratory Care (AARC) has added The Diagnostics Division of Bayer
HealthCare LLC, a member of the Bayer Group (NYSE:BAY) , to its Corporate
Partner Program. The program creates symbiotic relationships between
the only professional association for respiratory therapists and the
respiratory medical, diagnostic and pharmaceutical industry. Bayer Diagnostics
has a long history of developing and delivering innovative blood gas
products designed to meet the needs of respiratory therapists and their
“Companies, such as Bayer, that make up the respiratory care industry
are an important part of our community. We rely on them to provide us
with the cutting-edge technologies we need to deliver care, and they
rely on us to provide input into research and development of their new
and ongoing products,” says Kevin Shrake, MA, RRT, FAARC, AARC's Chief
This alliance will help Bayer Diagnostics create technologies that
enable respiratory therapists to better meet the needs of respiratory
patients. Bayer Diagnostics can help provide professional support and
education, while as a Corporate Partner they can receive input from
respiratory health professionals on their research and development projects.
“Bayer Diagnostics and the AARC share a similar mission of advancing
respiratory care, while meeting the needs of the respiratory care professional.
We are proud to be a Corporate Partner of the AARC, and expect
that our teams' collective enthusiasm, talent and resources will deliver
unparalleled benefits to the respiratory care community we serve,” comments
Michael Dalton, Director of Blood Gas for Bayer Diagnostics.
About the AARC
The AARC, the only professional membership association for respiratory
therapists, focuses primarily on respiratory therapy education and research.
Its goals are to ensure that respiratory patients receive safe and effective
care from qualified professionals and to benefit respiratory health
care providers. The Association continues to advocate, on behalf of
pulmonary patients, for appropriate access to respiratory services provided
by qualified professionals.
About Bayer Diagnostics
With approximately 7,000 employees worldwide and 2002 sales
of $1.9 billion, Bayer Diagnostics (www.bayerdiag.com), based in Tarrytown,
New York, U.S.A., is one of the largest diagnostic businesses in the
world. The organization supports customers in 100 countries through
an extensive portfolio of central, self-testing, nucleic acid and near
patient care diagnostics systems and services for use in the assessment
and management of health, including the areas of cardiovascular and
kidney disease, oncology, virology, women's health and diabetes. Bayer
Diagnostics' global headquarters in the United States operates as part
of Bayer HealthCare LLC a member of the worldwide Bayer HealthCare group.
About Bayer HealthCare
Bayer HealthCare, a subgroup of Bayer AG with annual sales
amounting to some 10 billion Euro, is one of the world's leading, innovative
companies in the health care and medical products industry. Bayer HealthCare
combines the global activities of the Animal Health, Biological Products,
Consumer Care, Diagnostics and Pharmaceuticals divisions. More than
34,000 employees work for Bayer HealthCare worldwide.
Their work at Bayer HealthCare is to discover and manufacture innovative
products for the purpose of improving human and animal health worldwide.
Their products enhance well-being and quality of life by diagnosing,
preventing and treating disease.
# # #